Vilon is a short synthetic dipeptide (Lys-Glu) belonging to the family of “peptide bioregulators” studied extensively by Russian research groups. This overview summarizes what the research explores and where it remains early-stage. All information here is for laboratory and educational research only. No compound referenced is approved for human or veterinary use, and nothing here is medical advice.
What is Vilon?
Vilon is the dipeptide Lys-Glu (KE), one of the short peptides studied as a regulator of gene expression and cellular processes. In the research literature it is grouped with other “Khavinson peptides” — very short sequences investigated for their roles in cellular signaling and biological regulation in study models.
What the research explores
Published research on short peptides including Lys-Glu has examined their effects on gene expression related to cellular aging and differentiation in cell-culture models. For example, studies have reported that short peptides can modulate the expression of genes associated with cell aging in human mesenchymal stem cell cultures [2], and can influence neuronal-differentiation markers in stem-cell models [1]. This is an early-stage area, and most evidence is preclinical (in-vitro and animal).
Research handling considerations
As a short peptide, Vilon is typically supplied lyophilized and reconstituted for laboratory work; see our peptide reconstitution guide for general handling background. These are general research-handling notes only, not instructions for use in humans or animals.
Frequently asked questions
What kind of peptide is Vilon?
Vilon is a dipeptide (Lys-Glu) — one of the shortest peptide bioregulators studied in the research literature.
Is the research conclusive?
No. The evidence base is early-stage and largely preclinical, so findings should be interpreted as directional rather than conclusive.
Selected research references
- [1] Caputi S, et al. (2019). Effect of short peptides on neuronal differentiation of stem cells. Int J Immunopathol Pharmacol. doi:10.1177/2058738419828613
- [2] Ashapkin V, et al. (2020). Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides. Mol Biol Rep. doi:10.1007/s11033-020-05506-3
Reference metadata sourced via PubMed.
Explore compounds studied in immune research in our IMMUNITY collection, or use the Research Finder to navigate by goal. Join the research list for 10% off your first order with code RESEARCH10.
Disclaimer: All products and information provided by BioRegen are for laboratory and educational research purposes only. Nothing here is medical advice, and no compound referenced is approved for human or veterinary use.
